| pubmed-article:11697833 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0679729 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C1518578 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0817096 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0439801 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:11697833 | lifeskim:mentions | umls-concept:C0205087 | lld:lifeskim |
| pubmed-article:11697833 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11697833 | pubmed:dateCreated | 2001-11-7 | lld:pubmed |
| pubmed-article:11697833 | pubmed:abstractText | Concurrent platinum etoposide chemotherapy given in combination with hyperfractionated thoracic radiation therapy (HTRT) in limited disease (LD) small cell lung cancer (SCLC) is associated with a high response rate and significant prolongation of survival. Given these results, the Hellenic Cooperative Oncology Group (HeCOG) performed a multicenter randomized phase II study in patients with LD SCLC to evaluate the timing of HTRT (early vs. late) when given concurrently with chemotherapy. | lld:pubmed |
| pubmed-article:11697833 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11697833 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11697833 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11697833 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11697833 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11697833 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11697833 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11697833 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:PavlidisNN | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:ZamboglouNN | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:KosmidisPP | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:FountzilasGG | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:BriassoulisEE | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:KardamakisDD | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:TsavdaridisDD | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:KalofonosH... | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:SkarlosD VDV | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:SamantasEE | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:TzitzikasJJ | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:TsekerisPP | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:PanoussakiEE | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:TsiakopoulosE... | lld:pubmed |
| pubmed-article:11697833 | pubmed:author | pubmed-author:KouvatseasGG | lld:pubmed |
| pubmed-article:11697833 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11697833 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:11697833 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11697833 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11697833 | pubmed:pagination | 1231-8 | lld:pubmed |
| pubmed-article:11697833 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:meshHeading | pubmed-meshheading:11697833... | lld:pubmed |
| pubmed-article:11697833 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11697833 | pubmed:articleTitle | Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). | lld:pubmed |
| pubmed-article:11697833 | pubmed:affiliation | Athens Medical Center, Greece. hecogoff@otenet.gr | lld:pubmed |
| pubmed-article:11697833 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11697833 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11697833 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11697833 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:11697833 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
